Licarete, E.; Rauca, V.F.; Luput, L.; Drotar, D.; Stejerean, I.; Patras, L.; Dume, B.; Toma, V.A.; Porfire, A.; Gherman, C.;
et al. Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment. Int. J. Mol. Sci. 2020, 21, 2968.
https://doi.org/10.3390/ijms21082968
AMA Style
Licarete E, Rauca VF, Luput L, Drotar D, Stejerean I, Patras L, Dume B, Toma VA, Porfire A, Gherman C,
et al. Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment. International Journal of Molecular Sciences. 2020; 21(8):2968.
https://doi.org/10.3390/ijms21082968
Chicago/Turabian Style
Licarete, Emilia, Valentin Florian Rauca, Lavinia Luput, Denise Drotar, Ioana Stejerean, Laura Patras, Bogdan Dume, Vlad Alexandru Toma, Alina Porfire, Claudia Gherman,
and et al. 2020. "Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment" International Journal of Molecular Sciences 21, no. 8: 2968.
https://doi.org/10.3390/ijms21082968
APA Style
Licarete, E., Rauca, V. F., Luput, L., Drotar, D., Stejerean, I., Patras, L., Dume, B., Toma, V. A., Porfire, A., Gherman, C., Sesarman, A., & Banciu, M.
(2020). Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment. International Journal of Molecular Sciences, 21(8), 2968.
https://doi.org/10.3390/ijms21082968
